£32,780-£41,093: Wellcome Sanger Institute: A position is now available for a highly motivated Postdoctoral Fellow to join the research group of Ana Cvejic, Peter Campbell and Open Targets pa... Hinxton, Cambridgeshire

£37,865-£45,359: Wellcome Sanger Institute: The Opportunity: We are looking for a senior bioinformatician (data manager), who has experience of handling large genomic datasets, to look after ... Hinxton, Cambridgeshire

Notice NOT-AA-21-039 from the NIH Guide for Grants and Contracts

Required: PhD degree in epidemiology, bioinformatics, computer science or related area, OR MD with demonstrated advanced training in epidemiology (a minimum of…
From Medical College of Wisconsin - Wed, 14 Jul 2021 15:08:22 GMT - View all Milwaukee, WI jobs

Notice NOT-EB-21-022 from the NIH Guide for Grants and Contracts

Notice NOT-MH-21-315 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-MH-21-205 from the NIH Guide for Grants and Contracts. Reissue of RFA-MH-19-400. This funding opportunity announcement (FOA), in support of the NIH Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative, is one of several FOAs aimed at supporting transformative discoveries that will lead to breakthroughs in understanding human brain function. Guided by the long-term scientific plan, BRAIN 2025: A Scientific Vision, this FOA specifically seeks to support efforts addressing core ethical issues associated with research focused on the human brain and resulting from emerging technologies and advancements supported by the BRAIN Initiative. The hope is that efforts supported under this FOA might be both complementary and integrative with the transformative, breakthrough neuroscience discoveries supported through the BRAIN Initiative.

5.Nimbly adapts bioinformatics tools, visualization packages, and annotation resources to perform accurate research analysis – flexibility and competency in…
From Medical College of Wisconsin - Wed, 14 Jul 2021 03:08:29 GMT - View all Milwaukee, WI jobs

Notice NOT-OD-21-151 from the NIH Guide for Grants and Contracts

Notice NOT-HL-21-021 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-HL-22-014 from the NIH Guide for Grants and Contracts. The National Institutes of Health (NIH) participating Institutes and Centers, in coordination with the U.S. Food and Drug Administration (FDA), seeks highly meritorious clinical trial applications proposing to explore and enable the development of safe and effective regenerative medicine (RM) interventions using adult stem cells. This Funding Opportunity Announcement (FOA), issued as part of the Regenerative Medicine Innovation Project (RMIP), represents one step in fulfilling a statutory provision set forth in the 21st Century Cures Act. Applications submitted in response to this bi-phasic, milestone-driven cooperative agreement FOA are expected to propose highly innovative projects with a focus on solutions to widely-recognized issues in the development of safe and effective RM therapies. Of particular interest are projects using RM products that have undergone appropriate product development and pre-clinical studies and have demonstrated readiness to advance into clinical trials. This FOA seeks Phase I and beyond clinical trial applications that present a strong scientific rationale for the proposed clinical trial and a comprehensive scientific and operational plan. Trials must be relevant to the research mission of one or more participating NIH Institutes and Centers and meet the NIH definition of a clinical trial (see NOT-OD-15-015). Applications are expected to include plans for project management, participant recruitment and retention, performance milestones, conduct of the trial, and dissemination of results. Before the time of award and if applicable, successful applicants must obtain an Investigational New Drug (IND) authorization or Investigational New Device Exemption (IDE) approval to administer the product to humans. Successful applicants proposing the use of adult stem cells as a clinical intervention will be asked to make available representative samples of the source stem cell and clinical-grade stem cell-derived product for in-depth and independ

Organization U.S. Department of Agriculture (USDA) Reference Code USDA-ARS-2021-0183 How to Apply Connect with ORISE...on the GO! Download the new ORISE GO…
From Oak Ridge Associated Universities - Mon, 12 Jul 2021 20:11:45 GMT - View all Kearneysville, WV jobs

Notice NOT-HS-21-017 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-RM-21-025 from the NIH Guide for Grants and Contracts. The purpose of the FIRST Cohort is to transform culture at NIH-funded extramural institutions by building a self-reinforcing community of scientists committed to diversity and inclusive excellence (defined below). Implementing and sustaining cultures of inclusive excellence within the program has the potential to be transformational for biomedical research at the awardee institutions and beyond. This community will be built through recruitment of faculty who are competitive for an advertised research tenure-track or equivalent faculty position (positions must be at the Assistant Professor (or equivalent) level), have not held a position at this level, and have demonstrated strong commitment to promoting diversity and inclusive excellence.

£45,516-£54,524: Wellcome Sanger Institute: The Opportunity: The Teichmann lab is seeking an enthusiastic and skilled Principal Bioinformatician to contribute to the group’s cell atlasing res... Hinxton, Cambridgeshire

Funding Opportunity RFA-LM-21-002 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites cooperative agreement (U24) applications for the Network of the National Library of Medicine (NNLM) All of Us Program Center (NACP). The mission of the NNLM is to provide U.S. health professionals, researchers, public health workforce, educators, and the public with equal access to biomedical and health information resources and data. NNLMs main goals are to work through libraries and other members to support a highly-trained workforce for biomedical and health information resources and data, improve health literacy, and increase health equity through information. The NNLM All of Us National Program Center (NAPC) will serve as the coordinating center and be responsible for the engagement, programs, partnerships, activities, and training offered by NNLM in support of the NIH All of Us Research Program. All of Us is working to improve health care through research by building a diverse database that can inform thousands of studies on a variety of health conditions. The NACP will continue to improve and innovate in two main functional areas: Training and Education, and Community Engagement. These two functional areas collaborate, coordinate, and cooperate to design, deliver, report, and evaluate innovative, responsive, and effective programs and services. They also work together to increase awareness about the NIH All of Us Research Program and to improve the health, digital, and related literacy skills that allow the general public to participate in long-term clinical research programs.

Funding Opportunity PAR-21-247 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits grant applications to catalyze major advances in single-molecule protein sequencing through technology development. The goal of this initiative is to achieve technological advances over the next five years that enable generation of protein sequencing data at sufficient scale, speed, cost and accuracy to use routinely in studies of genome biology and function, and in biomedical and clinical research in general.

Funding Opportunity PAR-21-274 from the NIH Guide for Grants and Contracts. Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) will support the program "Cancer Target Discovery and Development (CTD2, pronounced cee-tee-dee-squared). CTD2 is focused on efforts that advance cancer research by bridging the knowledge gap between the large volumes of comprehensive molecular characterizations of many cancer types and studies of the underlying etiology of cancer development, progression, and/or metastasis. The primary purpose of CTD2 is to advance the following areas: Improving the understanding of how mutations in cancer-associated genes affect the protein activity (e.g., gain-of-function, loss-of-function, or neomorphic function) within the cellular pathway(s) they are part of and the cellular changes that result within the context of various tumors and the microenvironment; Identifying new molecular targets with the goal to understand their wiring mechanisms and how overcome innate and/or acquired resistance to therapies, particularly clinical resistance related to inter- and intra- tumor heterogeneity; and Developing efficient strategies to identify appropriate multiple targets and optimal combination of perturbagens (chemical or biological; immunotherapeutics being a prime example of the latter) with the potential to eliminate all cancer cells, despite their clonal heterogeneity and their surrounding microenvironment.

Our growing team of Software Engineers are responsible for building one-of-a-kind innovative software solutions for the processing, storage, analysis, and…
From Indeed - Fri, 09 Jul 2021 21:25:42 GMT - View all Marshfield, WI jobs

Experience with bioinformatics and handling large data sets. MS degree with 4-8 years experience in industrial environment or PhD degree in a scientific… $60,000 - $110,000 a year
From Indeed - Fri, 09 Jul 2021 19:41:17 GMT - View all Madison, WI jobs